These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23402973)

  • 1. Clearance and bioavailability study through arterio-venous drug concentrations relationship.
    Fagiolino P; Vázquez M; Eiraldi R
    Eur J Pharm Sci; 2013 Mar; 48(4-5):825-9. PubMed ID: 23402973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences.
    Syvänen S; Blomquist G; Appel L; Hammarlund-Udenaes M; Långström B; Bergström M
    Eur J Clin Pharmacol; 2006 Oct; 62(10):839-48. PubMed ID: 16896783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of the arterial-venous plasma concentration difference in clearance studies.
    Chiou WL; Lam G
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):197-203. PubMed ID: 7095918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude and time-course of arterio-venous differences in blood-alcohol concentration in healthy men.
    Jones AW; Lindberg L; Olsson SG
    Clin Pharmacokinet; 2004; 43(15):1157-66. PubMed ID: 15568892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial-venous plasma concentration differences of 6-chloro-2-pyridylmethyl nitrate in humans after sublingual administration.
    Terada T; Ishibashi K; Tsuchiya T; Noguchi H; Sugiyama A; Nakashima M; Kanamaru M; Ishimura T
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):331-9. PubMed ID: 2727387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Feb; 98(2):748-62. PubMed ID: 18506769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences.
    Gumbleton M; Oie S; Verotta D
    Br J Clin Pharmacol; 1994 Nov; 38(5):389-400. PubMed ID: 7893578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration.
    Chiou WL; Lam G; Chen ML; Lee MG
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):27-39. PubMed ID: 7291727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conceptual underestimation of the total body clearance by the sum of clearances of individual organs in physiologically based pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Dec; 101(12):4660-5. PubMed ID: 23001916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between steady state blood concentrations and cardiac output during intravenous infusions.
    Upton RN
    Biopharm Drug Dispos; 2000 Mar; 21(2):69-76. PubMed ID: 11100908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
    Stepensky D
    Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics.
    Hermann DJ; Egan TD; Muir KT
    Clin Pharmacol Ther; 1999 May; 65(5):511-8. PubMed ID: 10340916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling.
    Hahn A; Nics L; Baldinger P; Ungersböck J; Dolliner P; Frey R; Birkfellner W; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Neuroimage; 2012 Aug; 62(1):199-206. PubMed ID: 22579604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body.
    Chiou WL; Lam G; Chen ML; Lee MG
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):17-26. PubMed ID: 7058288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.